Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies

Blood Reviews
Denis C F NoubouossieKenneth I Ataga

Abstract

Sickle cell disease (SCD) is a hypercoagulable state. Patients exhibit increased platelet activation, high plasma levels of markers of thrombin generation, depletion of natural anticoagulant proteins, abnormal activation of the fibrinolytic system, and increased tissue factor expression, even in the non-crisis "steady state." Furthermore, SCD is characterized by an increased risk of thrombotic complications. The pathogenesis of coagulation activation in SCD appears to be multi-factorial, with contributions from ischemia-reperfusion injury and inflammation, hemolysis and nitric oxide deficiency, and increased sickle RBC phosphatidylserine expression. Recent studies in animal models suggest that activation of coagulation may contribute to the pathogenesis of SCD, but the data on the contribution of coagulation and platelet activation to SCD-related complications in humans are limited. Clinical trials of new generations of anticoagulants and antiplatelet agents, using a variety of clinical endpoints are warranted.

References

Jan 1, 1978·Stroke; a Journal of Cerebral Circulation·K H MerkelM J Post
Jun 1, 1975·British Journal of Haematology·J LeslieY B Gordon
Feb 27, 1992·The New England Journal of Medicine·R AdamsD Hess
Nov 21, 1991·The New England Journal of Medicine·P F MilnerJ Smith
Jan 1, 1987·Acta Haematologica·M A BabikerA M Gader
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L McEvoyR A Schlegel
Mar 1, 1985·The Journal of Pediatrics·E M GordonP F Coccia
Apr 1, 1974·Archives of Internal Medicine·T A Bensinger, P N Gillette
Jan 1, 1984·Acta Haematologica·M A ZagoC Bottura
Jan 1, 1981·Acta Haematologica·N O OsamoA A Famodu
Feb 1, 1980·The Journal of Pediatrics·P Mehta, J Mehta
Jul 1, 1980·Journal of Clinical Pathology·M W KennyJ Stuart
Apr 1, 1995·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·D HaggerD Samson
Dec 1, 1994·American Journal of Hematology·P A LaneR A Marlar
Jun 9, 1994·The New England Journal of Medicine·O S PlattP P Klug
Apr 1, 1994·American Journal of Hematology·R J AdamsA Clary
Jan 1, 1993·Acta Haematologica·M A el-HazmiH Bahakim
Apr 1, 1996·American Journal of Hematology·P V BrowneR P Hebbel
Jul 1, 1996·Hematology and Cell Therapy·B NsiriS Machghoul
Jan 1, 1997·Journal of Child Neurology·D A Tam
May 1, 1997·The Journal of Laboratory and Clinical Medicine·T WunA Cheung
Apr 8, 1998·British Journal of Haematology·T WunF Tablin
Jun 13, 1998·The Journal of Clinical Investigation·A SoloveyR P Hebbel
Oct 16, 1999·The Journal of Laboratory and Clinical Medicine·M P WestermanP Williamson
Sep 14, 2000·The New England Journal of Medicine
Dec 12, 2001·Pediatrics International : Official Journal of the Japan Pediatric Society·A K Bayazit, Y Kilinç
Jan 5, 2002·American Journal of Hematology·J B SchnogR A Rojer
Oct 24, 2002·Blood·Neil M MatsuiStephen H Embury
Nov 1, 2002·American Journal of Hematology·Abraham SumozaVirgil Fairbanks
Jul 11, 2003·Pathophysiology of Haemostasis and Thrombosis·H Coenraad HemkerSuzette Béguin
Sep 19, 2003·Pathophysiology of Haemostasis and Thrombosis·H C HemkerS Béguin
Jul 25, 1963·The New England Journal of Medicine·J E SALVAGGIOC H BANOV
Oct 9, 2003·British Journal of Haematology·Elizabeth A ManciUNKNOWN Investigators of the Cooperative Study of Sickle Cell Disease
Nov 15, 2003·Blood·Carolyn HoppeUNKNOWN CSSCD Investigators

❮ Previous
Next ❯

Citations

May 3, 2016·British Journal of Haematology·Robert P Hebbel, Nigel S Key
Feb 22, 2017·Frontiers in Pediatrics·Richard H Ko, Courtney D Thornburg
Apr 30, 2017·Journal of Thrombosis and Haemostasis : JTH·R G HoltD B Khismatullin
Jul 4, 2017·Journal of Thrombosis and Haemostasis : JTH·E Sparkenbaugh, R Pawlinski
Feb 8, 2018·Pediatric Blood & Cancer·J Brett HeimlichKenneth I Ataga
Mar 14, 2018·The American Journal of Dermatopathology·Heather ReaginJoseph Susa
Sep 7, 2018·American Journal of Hematology·Lewis L HsuUNKNOWN HESTIA1 Investigators
Aug 2, 2018·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Angela RiversDonald Lavelle
Jan 9, 2019·Journal of Thrombosis and Haemostasis : JTH·J W Weisel, R I Litvinov
Dec 1, 2018·Expert Opinion on Pharmacotherapy·Lidiane Torres, Nicola Conran
Oct 18, 2018·Annual Review of Pathology·Prithu SunddEnrico M Novelli
Jan 22, 2019·European Journal of Haematology·Andrea PiccinOwen P Smith
Feb 19, 2019·Expert Review of Hematology·Foluso Joy OgunsileSophie Lanzkron
Oct 28, 2019·Blood Advances·Md Nasimuzzaman, Punam Malik
Apr 5, 2018·Clinical Hemorheology and Microcirculation·Camille FaesRafal Pawlinski
Dec 6, 2018·Nature Reviews. Drug Discovery·Marilyn J TelenGregory M Vercellotti
Aug 14, 2019·JBI Database of Systematic Reviews and Implementation Reports·Charles G FahrenholtzJennifer B Martin
Apr 12, 2019·Clinical Pharmacokinetics·Carl AmilonBengt Hamrén
Sep 3, 2019·Frontiers in Neurology·Hanne StotesburyFenella J Kirkham
Jul 30, 2020·International Journal of Molecular Sciences·Maria A Lizarralde-Iragorri, Arun S Shet
Sep 26, 2020·Expert Review of Hematology·Jaime Ribeiro-FilhoMarilda Souza Goncalves
Aug 9, 2020·F1000Research·Parul Rai, Kenneth I Ataga
Dec 4, 2016·Hematology·Ted Wun, Ann Brunson
Jan 1, 2018·Expert Opinion on Orphan Drugs·Kenneth I Ataga, Payal C Desai
Apr 2, 2020·Frontiers in Immunology·Elie NaderPhilippe Connes
Mar 16, 2018·Nature Reviews. Disease Primers·Gregory J KatoElliott P Vichinsky
May 2, 2017·ISBT Science Series·Rustem I Litvinov, John W Weisel
May 23, 2020·Haematologica·Nicola Conran, Erich V De Paula
Aug 21, 2020·Haematologica·Arun S ShetRakhi P Naik
Nov 30, 2020·British Journal of Haematology·Abdoul K DembéléCaroline Le Van Kim
Jan 7, 2021·Annals of Hematology·Valéria Sutana LadeiraDanyelle Romana Alves Rios
Nov 23, 2020·Thrombosis Research·Valéria Sutana LadeiraDanyelle Romana Alves Rios
Jan 28, 2021·Journal of Clinical Medicine·Marie-Thérèse Hopp, Diana Imhof
Feb 5, 2021·Research and Practice in Thrombosis and Haemostasis·Julien DemagnyAgnès Veyradier
Dec 11, 2020·Advances in Hematology·David SackeyEdeghonghon Olayemi
Feb 16, 2021·Annals of Hematology·Betânia Lucena Domingues HatzlhoferMarcos André Cavalcanti Bezerra
Mar 5, 2021·Transfusion·Kenneth I AtagaNigel S Key
Oct 16, 2020·Haematologica·Arun S ShetRakhi P Naik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia Cerebrovascular Disease

Basal ganglia cerebrovascular disease is a condition where the blood vessels in the basal ganglia are damaged or malfunction. Discover the latest research on basal ganglia cerebrovascular disease here.

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.